Summary
Studies on altering the immunogenicity of isolated Meth A surface membranes are described. Balb/c mice, the species of origin of the transplantable Meth A methylcholanthrene-induced lymphosarcoma were immunized IP on days 0 and 1 with isolated Meth A membrane treated in various ways. The mice were challenged IP on day 4 with varying numbers of viable Meth A cells. A 2,500 Meth A cell challenge is uniformly lethal to Balb/c mice. Immunization with unaltered membranes protects 50%–70% of animals against a 50,000 cell challenge. Incorporation of membranes in Freund's complete adjuvant destroys the membranes' immunizing capacity. Pertussis vaccine increases membrane TSTA immunogenicity in an apparently nonspecific way, so that 80%–90% of the mice are protected against a 250,000 cell challenge. Membranes reacted with diazotized arsanilate, neuraminidase, tannic acid, bis-diazobenzidine, and heparin have diminished immunogenicity. Poly-l-lysine and certain lectins enhance immunogenicity. Concanavalin A is the most potent of the lectins. Membranes reacted with this substance protect 60%–70% of animals against a 600,000 cell challenge.
Similar content being viewed by others
References
Anaclerio A, Waterfield JD, Moller G (1974) Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo. J Immunol 113:870
Bretscher P, Cohn M (1970) A theory of self-nonself discrimination. Science 169:1042
Dixon M, Webb EC (1958) In: Enzymes. Longman, Green, London, p 51
Flkoff RM, Dutton RW (1977) Evidence that concanavalin A induces cytotoxicity in the same subclass of T cells as does alloimmunization. J Immunol 118:1600
Finney DJ (1948) The Fisher Vater test of significance in 2 × 2 contingency tables. Biometrika 25:145
Frenster JH (1976) Phytohemagglutinin-activated autochthonous lymphocytes for systemic immunotherapy of human neoplasms. Ann NY Acad Sci 227:45
Glaser M (1978) Specific immune response against tumor-as-sociated antigens of a syngeneic simian virus 40-induced sarcome in mice. J Natl Cancer Inst 61:1351
Goldstein IJ, So LL, Yang Y, Callies QC (1969) The interaction of concanavalin A with IgM and the glycoprotein phytohemagglutinins of the wax bean and the soy bean. J Immunol 103:695
Kind LS, Peterson WA (1968) Concanavalin A in vivo: Induction of hemorragic skin lesions (arthus-like reactions) in mice. Science 160:312
Lee JM, Olitsky PKA (1955) Simple method for enhancing development of acute disseminated encephalomyelitis in mice. Proc Soc Exp Biol Med 89:263
Likhite V, Sehon A (1967) In: Williams CA, Chase MW (eds) Methods in immunology and immunochemistry, vol 1. Academic, New York, p 165
McCollester DL (1970) Isolation of Meth A cell surface membranes possessing tumor-specific transplantation antigen activity. Cancer Res 30:2832
Möller G (1970) Immunocyte triggering. Cell Immunol 1:573
Morse SI, Riester SK (1967) Studies on the leukocytosis and lymphocytosis induced by bordetella pertussis. II. The effect of pertussis vaccine on the thoracic duct lymphs and lymphocytes of mice. J Exp Med 125:619
Moscona AA (1971) Embryonic and neoplastic cell surfaces: availability of receptors for concanavalin A and wheat germ agglutinin. Science 171:905
Munoz J (1964) Effect of bacteria and bacterial products on antibody response. Adv Immunol 4:397
Nirmul G, Severin C, Taub RN (1972) In vivo effects on concanavalin A. Immunosuppressive effects. Transplantation 14:91
Nisonoff A (1967) Coupling of diazonium compounds to proteins. In: Williams CA, Chase MW (eds) Methods in immunology and immunochemistry, vol 1. Academic, New York, p 120
Old LJ, Boyse EA, Clarke DA, Carswell EA (1962) antigenic properties of chemically induced tumors. Ann NY Acad Sci 101:80
Peavy DL, Pierce CW (1974) Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells. J Exp Med 140:356
Schwartz HJ, Leon MA, Pelley RP (1970) Concanavalin A-induced release of skin-reactive factor from lymphoid cells. J Immunol 104:265
Sela M (1969) Antigenicity: some molecular aspects. Science 166:1365
Shoham J, Inbar M, Sachs L (1970) Differential toxicity on normal and transformed cells in vitro and inhibition of tumor development in vivo by concanavalin A. Nature 227:1244
Simmons RL, Rios A (1973) Differential effect on neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas. J Immunol 111:1820
Sjøgren HO (1964) II. Transplantation resistance to genetically compatible polyoma tumors induced by polyoma tumor homografts. J Natl Cancer Inst 32:645
Smith CAB (1954) In: Biomathematics. Hafner, New York, p 626
Stobo JD (1972) Phytohemagglutinin and concanavalin A: Probes for murine ‘T’ cell activation and differentiation. Transplant Rev 11:60
Stobo JD, Rosenthal AS, Paul WE (1972) Functional heterogeneity of murine lymphoid cells. I. Responsiveness to and surface binding of concanavalin A and phytohemagglutinin. J Immunol 108:1
Wissler RW, Craft D, Desden D, Polisky B, Dzola K (1968) Inhibition of the growth of Morris hepatoma (5123) in Buffalo rats using a mixture of pertussis vaccine and irradiated tumor. In: Dausset J, Hamburger J, Mathé G (eds) Advances in transplantation: Proceedings of the First International Congress of the Transplantation Society. Williams and Wilkins, New York, p 539
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCollester, D.L. Immunogenicity alterations induced in isolated Meth A sarcoma surface membranes. Cancer Immunol Immunother 8, 249–256 (1980). https://doi.org/10.1007/BF00206043
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00206043